Rheumatoid arthritis in the Middle East and Africa: are we any closer to optimising its management?
详细信息 查看全文
- 作者：Jamal Al Saleh (1)
Gaafar Ragab (2)
Peter Nash (3)
Hussein Halabi (4)
Ahmed Laatar (5)
Ali M. El-Sayed Yousef (6)
Hamdi Ehsouna (7)
Mohammed Hammoudeh (8)
1. Rheumatology Section ; Dubai Hospital ; Dubai ; United Arab Emirates
2. Cairo University ; Cairo ; Egypt
3. Department of Medicine ; University of Queensland ; Brisbane ; QLD ; Australia
4. King Faisal Specialist Hospital & Research Centre ; Riyadh ; Saudi Arabia
5. Department of Rheumatology ; University of Tunis El Manar ; Tunis ; Tunisia
6. Department of Rheumatology and Immunology ; Benha Teaching Hospital ; Benha ; Egypt
7. Faculty of Medicine ; Benghazi University ; Benghazi ; Libya
8. Department of Medicine ; Hamad General Hospital ; Doha ; Qatar - 刊名：Clinical Rheumatology
- 出版年：2015
- 出版时间：January 2015
- 年：2015
- 卷：34
- 期：1
- 页码：1-8
- 全文大小：3,738 KB
- 参考文献：1. El Zorkany B, Alwahshi HA, Hammoudeh M, Al Emadi S, Benitha R, Al Awadhi A, Bouajina E, Laatar A, El Badawy S, Al Badi M, Al-Maini M, Al Saleh J, Alswailem R, Ally MM, Batha W, Djoudi H, El Garf A, El Hadidi K, El Marzouqi M, Hadidi M, Maharaj AB, Masri AF, Mofti A, Nahar I, Pettipher CA, Spargo CE, Emery P (2013) Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution? Clin Rheumatol 32:151鈥?59 153-7" target="_blank" title="It opens in new window">CrossRef
2. Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van Riel P, Scholte M, Scott DL, Sokka T, Valesini G, van Vollenhoven R, Winthrop KL, Wong J, Zink A, van der Heijde D (2010) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 69:964鈥?75 CrossRef
3. Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, Bijlsma JW, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes JM, Kouloumas M, Kvien TK, Mariette X, Pavelka K, van Riel PL, Rubbert-Roth A, Scholte-Voshaar M, Scott DL, Sokka-Isler T, Wong JB, van der Heijde D (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73:492鈥?09 CrossRef
4. Almoallim H, Kamil A (2013) Rheumatoid arthritis: should we shift the focus from 鈥淭reat to Target鈥?to 鈥淭reat to Work?鈥? Clin Rheumatol 32:285鈥?87 CrossRef
5. Alawneh KM, Khassawneh BY, Ayesh MH, Smadi M (2014) Rheumatoid arthritis in Jordan: a cross sectional study of disease severity and associated comorbidities. Ther Clin Risk Manag 10:363鈥?66 CrossRef
6. Slimani S, Abbas A, Ben Ammar A, Kebaili D, Ali EH, Rahal F, Khamari MC, Baltache A, Khider I, Chiheub R, Khelif K, Akbi S, Rahmani S, Dahou-Makhloufi C, Brahimi-Mazouni N, Abtroun-Benmadi S, Ladjouze-Rezig A (2014) Characteristics of rheumatoid arthritis in Algeria: a multicenter study. Rheumatol Int
7. Lutf A, Poil AR, Hammoudeh M (2014) Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study. Int J Rheum Dis 17:63鈥?5 CrossRef
8. Malemba JJ, Mbuyi Muamba JM, Mukaya J, Bossuyt X, Verschueren P, Westhovens R (2013) Treatment of rheumatoid arthritis with methotrexate in Congolese patients. Clin Rheumatol 32:1323鈥?327 CrossRef
9. Hodkinson B, Musenge E, Ally M, Meyer PW, Anderson R, Tikly M (2012) Functional disability and health-related quality of life in South Africans with early rheumatoid arthritis. Scand J Rheumatol 41:366鈥?74 CrossRef
10. Ibn Yacoub Y, Amine B, Laatiris A, Hajjaj-Hassouni N (2012) Health-related quality of life in Moroccan patients with rheumatoid arthritis. Clin Rheumatol 31:1471鈥?477 CrossRef
11. Hodkinson B, Van Duuren E, Pettipher C, Kalla A, South African R, Arthritis A (2013) South African recommendations for the management of rheumatoid arthritis: an algorithm for the standard of care in 2013. S Afr Med J 103:576鈥?85 CrossRef
12. Mody GM (2013) AFLAR and SARAA 2013 Congress鈥攁 watershed event for rheumatology in Africa. Clin Rheumatol 32:925鈥?28 CrossRef
13. Dowman B, Campbell RM, Zgaga L, Adeloye D, Chan KY (2012) Estimating the burden of rheumatoid arthritis in Africa: a systematic analysis. J Glob Health 2:020406 CrossRef
14. Halabi H, Alarfaj A, Alawneh K, Alballa S, Alsaeid K, Badsha H, Benitha R, Bouajina E, Al Emadi S, El Garf A, El Hadidi K, Laatar A, Makhloufi CD, Masri AF, Menassa J, Al Shaikh A, Swailem RA, Dougados M (2014) Challenges and opportunities in the early diagnosis and optimal management of rheumatoid arthritis in Africa and the Middle East. Int J Rheum Dis. doi:10.1111/1756-1185X.12320
15. Hodkinson B, Tikly M, Adebajo A (2014) Rheumatoid arthritis in the developing world: stepping up to the challenge. Clin Rheumatol. doi:10.1007/s10067-10014-12690-10063
16. Hajjaj-Hassouni N, Al-Badi M, Al-Heresh A, Al-Emadi S, El Bawendi A, El Garf A, El Hadidi K, Halabi H, Hammoudeh M, El Hassani S, Al Maaini M, Nahar I, Ladjouze Rezig A, Sellami S, Sweiri W, Alswailem R, Traub B, Uthman I, van Duuren E, Zakraoui L, El Zorkany B, Carmona L, Dougados M (2012) The practical value of biologics registries in Africa and Middle East: challenges and opportunities. Clin Rheumatol 31:407鈥?16 CrossRef
17. Tikly M, Hodkinson B, Dheda K (2014) Biologic therapy for rheumatoid arthritis in developing countries鈥攁 place for non-TNF inhibitors as first-line treatment? Rheumatology (Oxford)
18. Zafar S, Badsha H, Mofti A, Delosantos A, Altares J, Matudio G, Kong KO (2012) Efforts to increase public awareness may result in more timely diagnosis of rheumatoid arthritis. J Clin Rheumatol 18:279鈥?82 CrossRef
19. Saberi M (2013) Arthritis in UAE: diagnose disease early. In. Gulfnews.com. Dubai, UAE: Al Nisr Publishing LLC. Available from: http://gulfnews.com/life-style/health/arthritis-in-uae-diagnose-disease-early-1.1207430
20. Ickinger C, Musenge E, Tikly M (2013) Patterns and predictors of joint damage as assessed by the rheumatoid arthritis articular damage (RAAD) score in South Africans with established rheumatoid arthritis. Clin Rheumatol 32:1711鈥?717 CrossRef
21. Hammoudeh M, Alarfaj A, Chen DY, Djoudi H, Youseif E, Zhu J (2013) Safety of tumor necrosis factor inhibitors use for rheumatoid arthritis and ankylosing spondylitis in Africa, the Middle East, and Asia: focus on severe infections and tuberculosis. Clin Rheumatol 32:293鈥?00 CrossRef
22. Pettipher C, Rudolph R, Musenge E, Tikly M (2014) A prospective study of anti-tumor necrosis factor therapy in South African rheumatoid arthritis patients. Int J Rheum Dis. doi:10.1111/1756-1185X.12299 - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Rheumatology - 出版者：Springer London
- ISSN：1434-9949
文摘